Civco Medical Solutions - Radiotherapy

Careers       Partnership Portal Login        News
 

Products
Products
Entire Site
 

Press Center

CIVCO Radiotherapy and Qfix Showcase as One Company at ESTRO 2023

Coralville, Iowa, (May 8, 2023) – CIVCO Radiotherapy and Qfix, now together as one company, will exhibit their innovative and patented solutions during the annual ESTRO Congress in Vienna, Austria, 12-16 May 2023. The company encourages attendees to visit booth #200 to experience many of these solutions firsthand. Live product demonstrations will include the Encompass™ SRS Immobilization System, the proprietary Integrated Shim™ and Fibreplast® thermoplastic solutions, and the Symphony® Patient Transfer System.

Read More...

CIVCO Radiotherapy to Exhibit Most Recent Innovations at ASTRO Annual Meeting

Coralville, Iowa, (Oct. 17, 2022) – CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will feature the TotalRT All in One Solution along with several innovative solutions in booth #3766 at the ASTRO Annual Meeting in San Antonio, Texas, October 23-25, 2022.

Read More...

CIVCO Radiotherapy to Feature TotalRT All in One Solution at AAPM Annual Meeting

Coralville, Iowa, (July 6, 2022) – CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will feature the TotalRT All in One Solution along with several innovative solutions during the annual AAPM Annual Meeting in Washington, D.C. July 10-14, 2022.

Read More...

CIVCO Radiotherapy to Unveil TotalRT All in One Solution at ESTRO 2022

Coralville, Iowa, (May 2, 2022) – CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will unveil the TotalRT All in One Solution along with several innovative solutions during the annual ESTRO Congress in Copenhagen, Denmark, 6-10 May 2022. A special product showcase will take place 6 May at 18:35.

Read More...

Blue Wolf Capital to Acquire CIVCO Radiotherapy from Roper Technologies

October 22, 2021 – NEW YORK – Blue Wolf Capital Partners LLC (“Blue Wolf”), a New York-based private equity firm, today announced it has entered into an agreement to acquire CIVCO Radiotherapy, a global leader of radiotherapy patient positioning and immobilization equipment, from Roper Technologies, Inc. (NYSE: ROP).

Read More...

CIVCO Radiotherapy and Leo Cancer Care Collaborate to Integrate Immobilsation Devices for Upright Patient Positioning

In an industry striving for sub-millimeter accuracy when delivering radiation to a cancerous tumor, motion is our enemy. Humans are built to move, therefore, to improve treatment accuracy and patient outcomes, reducing anatomical motion is paramount.

Read More...

CIVCO Radiotherapy to Exhibit In-Person at 2021 ASTRO Annual Meeting

Coralville, Iowa, (October 18, 2021) – CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will return to in-person exhibition, October 24 -27 in Chicago at the 2021 ASTRO Annual meeting, booth 944.

Read More...

CIVCO Radiotherapy to Exhibit In-Person and Virtually at ESTRO 2021

Coralville, Iowa, (August 23, 2021) – CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will return to in-person exhibition, August 27 -31 in Madrid, Spain at the ESTRO 2021 (European Society for Radiotherapy & Oncology) meeting, booth 210. CIVCO RT will also participate in the annual congress with a virtual booth to support attendees who choose not to travel onsite.

Read More...

European Installation and Service Agreement Announcement

Coralville, Iowa, (Feb. 17, 2021) – CIVCO Radiotherapy and Cablon Medical B.V., a Dutch medical device distribution and service company, have entered into an agreement that names Cablon Medical B.V. as CIVCO’s exclusive Installation and Service provider in Europe with the exception of Italy. Under this agreement, Cablon will provide installation and service for the Protura Robotic Patient Positioning System. CIVCO will continue to provide support as needed to our distributor in Italy, TEMA.

Read More...

CIVCO Radiotherapy Announces CE Mark Approval of Comfort Marker 2.0 Patient Marking System

Coralville, Iowa, (August 20, 2020) – CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions today announced the CE Mark approval for Comfort Marker 2.0 by Medical Precision B.V., an innovative marking system that applies patient reference points exactly, easily and with less pain than current patient marking systems such as tattoos.

Read More...

CIVCO Radiotherapy's Universal Couchtop Validated By Mevion Medical Systems

LITTLETON, MA (July 21, 2020) -- CIVCO Radiotherapy and Mevion Medical Systems are pleased to announce that Universal Couchtop™ is now validated and available on MEVION S250™ Series Proton Therapy Systems. The Universal Couchtop allows use of CIVCO’s full line of ProtonSeries™ products, including the ProForm™ head & neck immobilization solution.

Read More...

CIVCO Radiotherapy Expands Proton Therapy Immobilization Solutions, Releases UCT ProForm

Coralville, Iowa, (Sept. 10, 2019) –CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, today announced the release of the Universal Couchtop™ ProForm™ Head & Neck Solution, the newest development in their ProtonSeries™ family of products for proton therapy.

Read More...

CIVCO Radiotherapy and POLL Medical Announce FDA 510(k) Clearance to Market GrayDuck Tongue-Displacing and Immobilization Oral Stents

Coralville, Iowa, (April 11 , 2019) –CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, along with POLL Medical, are excited to announce U.S. Food and Drug Administration (FDA) 510(k) clearance to market GrayDuck Stents™.

Read More...

CIVCO Radiotherapy Announces FDA 510k Clearance and CE Mark of their Solstice SRS Immobilization System

Coralville, Iowa, (October 15, 2018) – CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, is delighted to announce FDA 510k clearance and EU CE mark for their Solstice™ SRS Immobilization System. The product will be available for shipment following its display at the American Society for Radiation Oncology (ASTRO) Meeting taking place October 21-24, 2018 in San Antonio, Texas.

Read More...

CIVCO Radiotherapy Partners with Medical Precision BV for NEW Semi-permanent Patient Marking System

Coralville, Iowa, (July 16, 2018) – CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions and Medical Precision BV have partnered to distribute Medical Precision’s next generation, innovative marking system* to apply patient reference points exactly, easily and with less pain than the current patient marking systems.

Read More...

CIVCO Radiotherapy Introduces New Five Year Warranty on Universal Couchtop™

Coralville, Iowa, (June 20, 2017) – CIVCO Radiotherapy, the leading provider of high quality, innovative, patient-centric radiotherapy solutions, has extended its manufacturer’s warranty on the Universal Couchtop (UCT) Long Extension and 1 Piece to a full five years, proving the outstanding quality and longevity of the Universal Couchtop. The new warranty went into effect June 1, 2017.

Read More...